Webster Financial Corporation <WBS.N>: Barclays Raises Target Price to $78 From $75
WBS•Related News
Opus Genetics completes enrollment in Phase 3 trial of OPGx-LCA5 gene therapy for LCA5 retinal disease
IRD•
Luckin Coffee Q2 FY26 net income climbs 16.1% to RMB 1.49 billion; total net revenues rise 28.5% to RMB 15.89 billion
LKNCY•
Tonix plans adaptive Phase 2 trial of TNX-4800 antibody to prevent Lyme disease, targets Q1 2027 start
TNXP•
Two Harbors says CCM merger wins approvals in all but one state
TWO•
Ocular Therapeutix Q2 FY26 net loss widens to $78.76 million; revenue rises 0.12% to $13.48 million
OCUL•